Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

A universal vaccine antigen for SARS-CoV-2

March 8, 2023 6:46 PM UTC

A SARS-CoV-2 spike protein vaccine designed based on phylogenetic analysis of thousands of viral sequences could help protect against COVID-19 by inducing broadly neutralizing antibodies that neutralize a wide range of variants.

An analysis of 2,675 SARS-CoV-2 S protein sequences collected in a public database before the Delta variant emerged identified high-frequency residues that reflect cross-clade generality in sequence evolution, which were incorporated into a protein subunit vaccine that was combined with adjuvants...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Wuhan University